Page 70 - Coronavirus Vaccine

Covid-19: Kerala reports 310 new cases in last 24 hours

Kerala reported 310 new cases of COVID-19 and eight deaths on Sunday, taking the total number of the infected to 65,33,786 and the death toll to 68,074 till date. Of the eight deaths, two occurred in the last few days but were not recorded due to late receipt of documents and six were designated as COVID-19 deaths after receiving appeals based on the new guidelines of the Centre and the directions of the Supreme Court, the Health Department said. Among the districts, Ernakulam reported the highest number of cases with 83 followed by Thiruvananthapuram (66) and Thrissur (30). A total of 458 people recovered today. The department said there were 2,680 active cases.

Covid-19: Shanghai lockdown triggers complaints as new cases rise

Health officials on Sunday reported 438 confirmed cases over the previous 24 hours, along with 7,788 asymptomatic ones.

China finds new coronavirus subtype as daily cases exceed 13,000

Almost 12,000 of the cases reported nationwide on Saturday were asymptomatic.

No impact on efficacy, safety of Covaxin: Bharat Biotech on WHO suspension

The vaccine manufacturer has said that the company is slowing down the production of Covaxin for facility optimization.

India registers 1,096 fresh Covid-19 infections, 81 more fatalities

A reduction of 432 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

Global Covid caseload rises to 490.6 million, fatalities reach 6.15 million

India accounts for the second highest caseload

WHO suspends UN supply of Bharat Biotech's Covaxin vaccine for Covid-19

This is to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection

US healthcare workforce still suffers 2 yrs into Covid-19 pandemic: Report

In 2020 alone, illness and injury increased by 40 per cent in healthcare and social assistance sectors, higher than any other private industry sector and led by the nursing professions: Report

Hong Kong urges Covid testing, Shanghai struggles under lockdown

Hong Kong reported another 5,820 cases Friday as the latest surge begins to taper off

In a first, Russia registers nasal version of Sputnik V Covid vaccine

Russian Health Ministry has registered the nasal version of Sputnik V, the world's first nasal vaccine against COVID-19."Russian Health Ministry registers the nasal version of Sputnik V, the world's first nasal vaccine against COVID-19," Sputnik V tweeted on late Friday.In January, the Russian news agency TASS reported that the nasal vaccine against the novel coronavirus infection will be in civil circulation and available for Russians within three to four months, quoting the director of the Gamaleya Centre, Alexander Gintsburg."The nasal vaccine for the civil circulation will be available in three to four months," the Director had said.It will be efficient against the new Omicron coronavirus strain, Gintsburg said."Laboratory tests show the Sputnik V protects against the Omicron in its ordinary injection form, and it will certainly be efficient in the nasal form," he added, according to TASS.In October last year, the Russian Ministry of Health issued the authorization to the Gamaleya

Booster dose of Covid vaccine needed to fight against Omicron: Study

Neutralising antibody levels waned after six months in those who were fully vaccinated against Covid with Covishield, Covaxin and a mix of both in the context of the Omicron variant, a study said

Bharat Biotech slows down COVAXIN production for facility optimisation

Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities

US lawsuit may not impact India launch of Gennova's mRNA vaccine

The vaccine is now under review by the regulator, and if approved, it may be ready for launch in the Indian market and will be the first mRNA Covid vaccine to be available here.

'Kids below 12 yrs who are at high risk can be considered for Covid vax'

Children mostly have mild Covid infection but those who are at high risk and have comorbidities can experience complications

India's cumulative Covid vaccination coverage crosses 1.84 mn

The official press release by the Union Ministry added that more than 16 lakh vaccine doses have been administered till 7 pm today

Bharat Biotech slows down Covaxin production as it sees decrease in demand

'For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities,' the Hyderabad-based company said

Maharashtra sees 123 Covid-19 cases, two deaths and 112 recoveries

So far, 77,25,451 people have been discharged post recovery, including 112 in the last 24 hours, leaving the state with 911 active cases, an official said

Pfizer Covid vax in kids aged 5-11 cut Omicron hospitalisations by 68%

A study, published in The New England Journal of Medicine, also confirms that vaccination reduced Covid hospitalisation in adolescents aged 12-18 and protected strongly against severe illness.

Power consumption grows steadily at 4.6% to 126.12 billion units in March

India's power consumption has grown steadily at 4.6 per cent yoy in Mar to 126.12 bn units (BU), showing the impact of early onset of summers and easing of lockdown restrictions by states.

Too early to do away with face masks, but onus on public, says experts

While some states have decided to stop penalising people for not wearing masks as COVID cases continue to drop, healthcare experts believe it is too early to do away with the restriction.